13.91
price down icon0.50%   -0.07
after-market 시간 외 거래: 13.96 0.05 +0.36%
loading
전일 마감가:
$13.98
열려 있는:
$14.13
하루 거래량:
363.24K
Relative Volume:
0.48
시가총액:
$431.89M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+7.08%
1개월 성능:
+6.75%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
Value
$13.75
$14.29
1주일 범위
Value
$12.78
$14.29
52주 변동 폭
Value
$12.33
$21.47

Grail Inc Stock (GRAL) Company Profile

Name
명칭
Grail Inc
Name
전화
650-771-9796
Name
주소
1525 O'BRIEN DRIVE, MENLO PARK
Name
직원
0
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
GRAL's Discussions on Twitter

Grail Inc 주식(GRAL)의 최신 뉴스

pulisher
01:05 AM

Grail (GRAL) Set to Announce Quarterly Earnings on Tuesday - MarketBeat

01:05 AM
pulisher
Nov 04, 2024

GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - WV News

Nov 04, 2024
pulisher
Oct 29, 2024

GRAIL to Announce Third Quarter 2024 Financial Results - StockTitan

Oct 29, 2024
pulisher
Oct 27, 2024

(GRAL) Trading Advice - Stock Traders Daily

Oct 27, 2024
pulisher
Oct 27, 2024

Google: The Bullish Pivot Before The Earnings Grail (NASDAQ:GOOG) - Seeking Alpha

Oct 27, 2024
pulisher
Oct 25, 2024

GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation - The Cancer Letter

Oct 25, 2024
pulisher
Oct 25, 2024

Nike x Wu-Tang Clan Reunite to Release Legendary Sneaker Grail — NIKE, Inc. - Nike

Oct 25, 2024
pulisher
Oct 25, 2024

Illumina Wins Court Fight With EU Over $7 Billion Grail Deal - MSN

Oct 25, 2024
pulisher
Oct 24, 2024

Real-world study of Grail’s Galleri consistent with trial data - BioWorld Online

Oct 24, 2024
pulisher
Oct 23, 2024

The Jeff Bezos-backed cancer treatment company is being sold for eight billion dollars - Telegrafi

Oct 23, 2024
pulisher
Oct 23, 2024

GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference - PR Newswire

Oct 23, 2024
pulisher
Oct 23, 2024

Health Beat: The 'holy grail' of cancer screening - 69News WFMZ-TV

Oct 23, 2024
pulisher
Oct 23, 2024

CEO & Director Of GRAIL Sold 51% Of Their Shares - Simply Wall St

Oct 23, 2024
pulisher
Oct 22, 2024

Company commits not to try to crack ‘holy grail’ cement-free formula - Irish Independent

Oct 22, 2024
pulisher
Oct 22, 2024

Grail appoints healthcare veteran Sarah Krevans to board By Investing.com - Investing.com Australia

Oct 22, 2024
pulisher
Oct 21, 2024

Grail appoints healthcare veteran Sarah Krevans to board - Investing.com

Oct 21, 2024
pulisher
Oct 21, 2024

GRAIL Appoints Sarah Krevans to Board of Directors - Quantisnow

Oct 21, 2024
pulisher
Oct 21, 2024

Layoff Tracker: Takeda Cuts More Employees, Total Exceeds 1,300 in 2024 - BioSpace

Oct 21, 2024
pulisher
Oct 17, 2024

Grail CEO Robert Ragusa sells $1.73 million in stock - Investing.com

Oct 17, 2024
pulisher
Oct 17, 2024

How the (GRAL) price action is used to our Advantage - Stock Traders Daily

Oct 17, 2024
pulisher
Oct 15, 2024

Health Headlines: Holy Grail of cancer screening - KPLC

Oct 15, 2024
pulisher
Oct 13, 2024

GRAIL, Inc. (GRAL): Jeff Bezos Is Buying This Stock Now - Insider Monkey

Oct 13, 2024
pulisher
Oct 10, 2024

Grail Inc. executive acquires over $1 million in company stock By Investing.com - Investing.com South Africa

Oct 10, 2024
pulisher
Oct 10, 2024

Grail Inc. executive acquires over $1 million in company stock - Investing.com India

Oct 10, 2024
pulisher
Oct 08, 2024

Best Life: The ‘Holy Grail’ for cancer screening - Action News 5

Oct 08, 2024
pulisher
Oct 04, 2024

Illumina Grail: European Court Limits Commission Jurisdictional Reach in Merger Cases - JD Supra

Oct 04, 2024
pulisher
Oct 02, 2024

Illumina falls amid reports of an EU order to sell Grail - MSN

Oct 02, 2024
pulisher
Oct 01, 2024

The Taxpayer-Funded GRAIL Galleri-Medicare Study: A Flawed Design - healthaffairs.org

Oct 01, 2024
pulisher
Oct 01, 2024

CRCM LP's Strategic Acquisition of GRAIL Inc Shares - GuruFocus.com

Oct 01, 2024
pulisher
Sep 29, 2024

Biotech company Grail to lay off 350, more than half in Bay Area - MSN

Sep 29, 2024
pulisher
Sep 24, 2024

GRAIL: Post-Spinoff, Illumina Maintains Control And Incentive To Support Success - Seeking Alpha

Sep 24, 2024
pulisher
Sep 24, 2024

Closing Strong: GRAIL Inc. (GRAL) Ends at 13.04, Down -6.52 from Last Close - The Dwinnex

Sep 24, 2024
pulisher
Sep 24, 2024

Gleeds to relocate to new Fitzrovia HQ - FMJ

Sep 24, 2024
pulisher
Sep 24, 2024

Illumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture - ANTARA English

Sep 24, 2024
pulisher
Sep 24, 2024

Gleeds to move into new London HQ next January - Building

Sep 24, 2024
pulisher
Sep 24, 2024

Ex-Linchpin director loses appeal of $150,000 penalty - Lawyerly

Sep 24, 2024
pulisher
Sep 23, 2024

486 Shares in Graham Holdings (NYSE:GHC) Purchased by King Luther Capital Management Corp - Defense World

Sep 23, 2024
pulisher
Sep 20, 2024

BreakingviewsLarry Fink’s private index dream may be holy grail - Reuters

Sep 20, 2024
pulisher
Sep 18, 2024

John P. Mullen Sells 6,718 Shares of Guidewire Software, Inc. (NYSE:GWRE) Stock - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

(09/18/24) GRAL: An Intriguing Biotech Name Active in Cancer Detection Test - Moneyshow.com

Sep 18, 2024
pulisher
Sep 16, 2024

Illumina/Grail: EU Court overturns approach to “killer acquisitions” - JD Supra

Sep 16, 2024
pulisher
Sep 16, 2024

With 59% ownership of the shares, GRAIL, Inc. (NASDAQ:GRAL) is heavily dominated by institutional owners - Simply Wall St

Sep 16, 2024
pulisher
Sep 12, 2024

We're Keeping An Eye On GRAIL's (NASDAQ:GRAL) Cash Burn Rate - Yahoo Finance

Sep 12, 2024
pulisher
Sep 11, 2024

Commission withdraws several decisions in the Illumina/GRAIL case - EU Reporter

Sep 11, 2024
pulisher
Sep 10, 2024

Illumina/Grail case: CJEU annuls Commission’s referral decision - Cuatrecasas

Sep 10, 2024
pulisher
Sep 09, 2024

Cœuré: Illumina/Grail decision will cause “more fragmented system” - Global Competition Review

Sep 09, 2024
pulisher
Sep 09, 2024

Grail’s Potential Turnaround: Seeking FDA Approval For Galleri (NASDAQ:GRAL) - Seeking Alpha

Sep 09, 2024
pulisher
Sep 08, 2024

GRAIL to focus on multi-cancer early detection; cuts workforce by 30% - MSN

Sep 08, 2024
pulisher
Sep 06, 2024

Battery company says it's achieved breakthrough charging time with 'holy grail' of EV tech: 'This car [ticks] all the boxes' - The Cool Down

Sep 06, 2024
pulisher
Sep 06, 2024

EU’s ability to challenge ‘killer acquisitions’ dealt a blow by Europe’s highest court - EURACTIV

Sep 06, 2024

Grail Inc (GRAL) 재무 분석

Grail Inc (GRAL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$226.42
price up icon 3.48%
diagnostics_research LH
$229.11
price up icon 0.85%
diagnostics_research WAT
$387.17
price down icon 0.04%
$154.96
price up icon 0.96%
diagnostics_research MTD
$1,385.79
price up icon 1.60%
$415.98
price up icon 0.35%
자본화:     |  볼륨(24시간):